OTC:$LUDG ), is pleased to announce a SEQUIRE Spotlight featuring Dr. Marvin S. Hausman M.D. SEQUIRE Spotlight- Host Jonathan Miller interviews Chief Science Officer: Dr. Marvin S. Hausman. The featured interview includes in-depth information about the company's recent patent filing, upcoming bladder cancer study and the companies moves towards filing an S1, a mini IPO with the SEC, with the eventual goal to uplist to the NASDAQ market. This comprehensive interview explains how Precision Genomics' groundbreaking technology could revolutionize the way we diagnose and treat today's most prevalent diseases such as cancer, heart disease and even long Covid. All of these conditions have chronic inflammation as an underlying causative problem and health issue. https://finance.yahoo.com/news/precision-geno...00758.html